Biomarin Pharmaceutical (BMRN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $54.68, -2.44% vs the prior close of $56.05.
- Volume 2.63M shares, 1.2x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BMRN dips 2.4% to $54.68. Closed at $54.68, -2.44% vs the prior close of $56.05. Day range $54.44–$56.53, opened at $56.41.
BMRN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — BMRN dips 2.4% to $54.68
- Closed at $54.68, -2.44% vs the prior close of $56.05. Day range $54.44–$56.53, opened at $56.41.
- Volume was 2.63M shares, 1.2x its 50-day average of 2.24M.
- Price is -13.1% vs its 50-day average ($62.96) and -6.6% vs its 200-day average ($58.56).
- 52-week range $49.26–$70.98; today's close sits at 25% of that range, 23.0% below the 52-week high.
Oct 15, 2026 — BMRN rises 1.7% to $56.05
- Closed at $56.05, +1.65% vs the prior close of $55.14. Day range $55.96–$57.59, opened at $56.45.
- Volume was 2.92M shares, 1.3x its 50-day average of 2.22M.
- Price is -11.2% vs its 50-day average ($63.09) and -4.3% vs its 200-day average ($58.58).
- 52-week range $49.26–$70.98; today's close sits at 31% of that range, 21.0% below the 52-week high.
Oct 14, 2026 — BMRN rises 1.4% to $55.14
- Closed at $55.14, +1.40% vs the prior close of $54.38. Day range $54.46–$55.56, opened at $54.75.
- Volume was 1.85M shares, 0.8x its 50-day average of 2.20M.
- Price is -12.7% vs its 50-day average ($63.17) and -5.9% vs its 200-day average ($58.60).
- 52-week range $49.26–$70.98; today's close sits at 27% of that range, 22.3% below the 52-week high.
Oct 13, 2026 — BMRN dips 1.8% to $54.38, a 3-month low
- Closed at $54.38, -1.82% vs the prior close of $55.39. Day range $53.93–$55.66, opened at $55.30.
- Volume was 2.66M shares, 1.2x its 50-day average of 2.19M.
- Price is -14.1% vs its 50-day average ($63.28) and -7.2% vs its 200-day average ($58.63).
- 52-week range $49.26–$70.98; today's close sits at 24% of that range, 23.4% below the 52-week high.
Oct 12, 2026 — BMRN rises 1.1% to $55.39
- Closed at $55.39, +1.08% vs the prior close of $54.80. Day range $54.90–$55.96, opened at $55.56.
- Volume was 2.36M shares, 1.1x its 50-day average of 2.19M.
- Price is -12.6% vs its 50-day average ($63.39) and -5.6% vs its 200-day average ($58.66).
- 52-week range $49.26–$70.98; today's close sits at 28% of that range, 22.0% below the 52-week high.
Oct 9, 2026 — BMRN ends flat (-0.2%) to $54.80, a 3-month low, 4 down days in a row
- Closed at $54.80, -0.16% vs the prior close of $54.89. Day range $54.48–$55.98, opened at $54.80.
- Volume was 2.15M shares, 1.0x its 50-day average of 2.17M.
- Price is -13.7% vs its 50-day average ($63.49) and -6.6% vs its 200-day average ($58.69).
- 52-week range $49.26–$70.98; today's close sits at 26% of that range, 22.8% below the 52-week high.
- That makes 4 straight losses.
Oct 8, 2026 — BMRN dips 0.6% to $54.89, a 3-month low, 3 down days in a row
- Closed at $54.89, -0.56% vs the prior close of $55.20. Day range $53.90–$54.97, opened at $54.95.
- Volume was 3.10M shares, 1.4x its 50-day average of 2.14M.
- Price is -13.7% vs its 50-day average ($63.60) and -6.5% vs its 200-day average ($58.71).
- 52-week range $49.26–$70.98; today's close sits at 26% of that range, 22.7% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — BMRN dips 1.8% to $55.20, a 3-month low
- Closed at $55.20, -1.81% vs the prior close of $56.22. Day range $54.76–$56.60, opened at $56.05.
- Volume was 2.08M shares, 1.0x its 50-day average of 2.14M.
- Price is -13.4% vs its 50-day average ($63.73) and -6.0% vs its 200-day average ($58.74).
- 52-week range $49.26–$70.98; today's close sits at 27% of that range, 22.2% below the 52-week high.
Oct 6, 2026 — BMRN dips 2.3% to $56.22, a 3-month low
- Closed at $56.22, -2.29% vs the prior close of $57.54. Day range $55.76–$57.88, opened at $57.54.
- Volume was 3.72M shares, 1.8x its 50-day average of 2.10M.
- Price is -12.0% vs its 50-day average ($63.87) and -4.3% vs its 200-day average ($58.72).
- 52-week range $49.26–$70.98; today's close sits at 32% of that range, 20.8% below the 52-week high.
- SEC filings that day: 8-K.
- This was a results day: the company filed an earnings release (8-K Item 2.02).
Oct 5, 2026 — BMRN rises 0.6% to $57.54
- Closed at $57.54, +0.63% vs the prior close of $57.18. Day range $56.82–$58.11, opened at $57.11.
- Volume was 2.41M shares, 1.2x its 50-day average of 2.09M.
- Price is -10.0% vs its 50-day average ($63.95) and -2.0% vs its 200-day average ($58.70).
- 52-week range $49.26–$70.98; today's close sits at 38% of that range, 18.9% below the 52-week high.
Oct 2, 2026 — BMRN dips 2.2% to $57.18, a 3-month low
- Closed at $57.18, -2.16% vs the prior close of $58.44. Day range $57.15–$58.73, opened at $58.52.
- Volume was 2.19M shares, 1.0x its 50-day average of 2.10M.
- Price is -10.6% vs its 50-day average ($63.98) and -2.5% vs its 200-day average ($58.67).
- 52-week range $49.26–$70.98; today's close sits at 36% of that range, 19.4% below the 52-week high.
BMRN latest news & SEC filings
Every SEC filing by or about BMRN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Friberg Gregory R had withheld for taxes 4,086 shares at $60.00 (≈$245.16K) on Sep 30, 2026; now holds 47,732
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 30, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Sep 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 14, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 14, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Davis George Eric sold 17,557 shares at $66.28 (≈$1.16M) on Sep 2, 2026
- Davis George Eric sold 17,557 shares at $66.28 (≈$1.16M) on Sep 2, 2026
- Davis George Eric sold 17,557 shares at $66.28 (≈$1.16M) on Sep 2, 2026
- Davis George Eric sold 17,557 shares at $66.28 (≈$1.16M) on Sep 2, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 2, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 31, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 6, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $989.71M (prior year $825.41M) (+19.9% vs Jun 30, 2025)
- Net income: $44.76M (prior year $240.53M) (-81.4% vs Jun 30, 2025)
- Diluted EPS: $0.23 (prior year $1.23) (-81.3% vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade BMRN
- Last results release: Oct 6, 2026 (8-K Item 2.02). Previous ones: Aug 6, 2026, May 4, 2026, Feb 23, 2026. Based on that rhythm, the next report is likely around Jan 5, 2027 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.36% (largest 2.6%).
- Liquidity: about 2.28M shares (≈$124.41M) trade per day on average.
- 52-week position: $54.68 vs a range of $49.26–$70.98 (25% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 20 sales; latest: George Eric Davis sold 17,557 shares on Sep 2, 2026.
- Latest filings: 8-K Oct 6, 2026; 8-K Sep 30, 2026; 8-K Sep 15, 2026.
- Share count: 193.57M shares outstanding (Jul 28, 2026), +0.8% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
BMRN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 56.41 | 56.53 | 54.44 | 54.68 | 2.63M |
| Oct 15, 2026 | 56.45 | 57.59 | 55.96 | 56.05 | 2.92M |
| Oct 14, 2026 | 54.75 | 55.56 | 54.46 | 55.14 | 1.85M |
| Oct 13, 2026 | 55.30 | 55.66 | 53.93 | 54.38 | 2.66M |
| Oct 12, 2026 | 55.56 | 55.96 | 54.90 | 55.39 | 2.36M |
| Oct 9, 2026 | 54.80 | 55.98 | 54.48 | 54.80 | 2.15M |
| Oct 8, 2026 | 54.95 | 54.97 | 53.90 | 54.89 | 3.10M |
| Oct 7, 2026 | 56.05 | 56.60 | 54.76 | 55.20 | 2.08M |
| Oct 6, 2026 | 57.54 | 57.88 | 55.76 | 56.22 | 3.72M |
| Oct 5, 2026 | 57.11 | 58.11 | 56.82 | 57.54 | 2.41M |
| Oct 2, 2026 | 58.52 | 58.73 | 57.15 | 57.18 | 2.19M |
| Oct 1, 2026 | 59.81 | 60.16 | 58.39 | 58.44 | 2.08M |
| Sep 30, 2026 | 59.90 | 60.71 | 59.37 | 60.00 | 1.80M |
| Sep 29, 2026 | 59.24 | 60.09 | 58.96 | 59.87 | 1.81M |
| Sep 28, 2026 | 59.87 | 60.07 | 58.74 | 59.46 | 2.36M |
| Sep 25, 2026 | 61.50 | 61.50 | 60.17 | 60.26 | 1.79M |
| Sep 24, 2026 | 62.21 | 62.33 | 61.13 | 61.35 | 1.66M |
| Sep 23, 2026 | 63.68 | 64.00 | 61.58 | 62.21 | 2.11M |
| Sep 22, 2026 | 64.34 | 64.79 | 63.35 | 63.37 | 1.96M |
| Sep 21, 2026 | 64.35 | 64.96 | 63.58 | 64.06 | 1.88M |
About Biomarin Pharmaceutical
Biomarin Pharmaceutical (BMRN) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in NOVATO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1048477.
BMRN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Elizabeth M Anderson | Director | Jun 4, 2026 |
| Barbara W. Bodem | Director | Jun 4, 2026 |
| Ian T Clark | Director | Jun 4, 2026 |
| Athena Countouriotis | Director | Jun 4, 2026 |
| Willard H Dere | Director | Jun 4, 2026 |
| Mark J Enyedy | Director | Jun 4, 2026 |
| Robert J. Hombach | Director | Jun 4, 2026 |
| Alexander Hardy | Chief Executive Officer | Mar 19, 2026 |
| Maykin Ho | Director | Jun 4, 2026 |
| Richard A Meier | Director | Feb 13, 2026 |
| Robert M Plenge | Director | Sep 14, 2026 |
| Timothy P Walbert | Director | Jun 4, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| George Eric Davis | EVP, Chief Legal Officer | Sep 3, 2026 |
| Gregory R Friberg | EVP, Chief R&D Officer | May 11, 2026 |
| Charles Greg Guyer | EVP, Chief Technical Officer | Mar 19, 2026 |
| Alexander Hardy | Chief Executive Officer | Mar 19, 2026 |
| Cristin Hubbard | EVP, Chief Commercial Officer | May 21, 2026 |
| Brian Mueller | EVP, Chief Financial Officer | Mar 19, 2026 |
| Rashmi Virendra Ramchandani | VP, Chief Accounting Officer | Jan 22, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 2, 2026 | George Eric Davis | Sale | 17,557 | $66.28 |
| Sep 2, 2026 | George Eric Davis | Sale | 17,557 | $66.28 |
| Sep 2, 2026 | George Eric Davis | Sale | 17,557 | $66.28 |
| Sep 2, 2026 | George Eric Davis | Sale | 17,557 | $66.28 |
| May 7, 2026 | Gregory R Friberg | Sale | 3,281 | $53.85 |
| May 7, 2026 | Gregory R Friberg | Sale | 3,281 | $53.85 |
| May 7, 2026 | Gregory R Friberg | Sale | 3,281 | $53.85 |
| May 7, 2026 | Gregory R Friberg | Sale | 3,281 | $53.85 |
| Mar 11, 2026 | Charles Greg Guyer | Sale | 16,486 | $60.46 |
| Mar 11, 2026 | Charles Greg Guyer | Sale | 16,486 | $60.46 |
| Mar 11, 2026 | Charles Greg Guyer | Sale | 16,486 | $60.46 |
| Mar 11, 2026 | Charles Greg Guyer | Sale | 16,486 | $60.46 |
| Feb 26, 2026 | George Eric Davis | Sale | 26,061 | $61.36 |
| Feb 26, 2026 | George Eric Davis | Sale | 26,061 | $61.36 |
| Feb 26, 2026 | George Eric Davis | Sale | 26,061 | $61.36 |
BMRN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $3.22B | $348.90M | 1.80 | $827.99M |
| Dec 31, 2024 | $2.85B | $426.86M | 2.21 | $572.84M |
| Dec 31, 2023 | $2.42B | $167.65M | 0.87 | $159.26M |
| Dec 31, 2022 | $2.10B | $141.56M | 0.75 | $175.90M |
| Dec 31, 2021 | $1.85B | $-64.08M | -0.35 | $304.54M |
Latest balance sheet: total assets $11.72B, total liabilities $5.40B, cash $874.00M (as of Jun 30, 2026).
BMRN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 6, 2026 | 8-K Item 2.02 (results) | $56.22 |
| Aug 6, 2026 | 8-K Item 2.02 (results) | $61.46 |
| May 4, 2026 | 8-K Item 2.02 (results) | $55.46 |
| Feb 23, 2026 | 8-K Item 2.02 (results) | $62.92 |
| Jan 26, 2026 | 8-K Item 2.02 (results) | $56.78 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $57.71 |
| Oct 27, 2025 | 8-K Item 2.02 (results) | $52.67 |
| Oct 7, 2025 | 8-K Item 2.02 (results) | $54.70 |
| Aug 4, 2025 | 8-K Item 2.02 (results) | $60.31 |
| May 1, 2025 | 8-K Item 2.02 (results) | $62.71 |
| Feb 19, 2025 | 8-K Item 2.02 (results) | $65.61 |
| Oct 29, 2024 | 8-K Item 2.02 (results) | $69.91 |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on BMRN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.